CFTR and cystic fibrosis: With the increasing adoption of highly effective CFTR modulators, the clinical phenotype of CF is shifting toward milder disease courses, which may also influence imaging strategies, potentially reducing the frequency of MRI follow-up or motivating the development of new, more sensitive MRI sequences tailored to subtle residual disease.